Work

Stratification by Risk Factors Predicts Survival on the Active Treatment Arm in a Randomized Phase II Study of Interferon-Gamma Plus/Minus Interferon-Alpha in Advanced Renal Cell Carcinoma (E6890)

Year: 2003

Type: article

Source: Medical Oncology

DOI: 10.1385/mo:20:3:271

Authors: Janice P. Dutcher, Jason P. Fine, Robert L. Krigel, Barbara A. Murphy, Paul L. Schaefer, Marc S. Ernstoff, Patrick J. Loehrer

Institutions: Lady of Mercy Medical Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Lankenau Medical Center, Vanderbilt University, Dartmouth College, Dartmouth–Hitchcock Medical Center, Dartmouth Cancer Center, Indiana University Indianapolis, Indiana University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute

Awards: G1011812605, Eastern Cooperative Oncology Group, G1422427855, Eastern Cooperative Oncology Group (Main Institution), G286468852, G3210846400, G5733733469, Eastern Cooperative Oncology Group, Eastern Cooperative Oncology Group, ECOG Statistical Office, Eastern Cooperative Oncology Group Operations Office, G964706321

OpenAlex ID: W2066845644

FWCI: 1.548

Cites: 25

Cited by: 17

Related to: 10